| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
Form 4: Main Jennifer Elizabeth, Director
Received 3,113 shares as a grant or award |
| 19 Oct 2026 |
Form 3: Main Jennifer Elizabeth, Director
No securities owned |
| 16 Oct 2026 |
Form 4: Misencik Tiffani, SVP, Chief Growth Officer
Gave up 9,994 shares to cover exercise price or tax ($239K) · Sold 5,812 shares ($138K) |
| 15 Oct 2026 | 144 |
| 15 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure
McLean, VA — October 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that its Board of Directors (“Board”) has appointed Jennifer (Jenni) Main as a dir... |
| 01 Oct 2026 | SCHEDULE 13G/A |
| 22 Sep 2026 |
Form 4: Garis Douglas Michael, EVP&CFO
Sold 9,025 shares ($276K) |
| 21 Sep 2026 | 144 |
| 16 Sep 2026 |
Form 4: Letham Thomas Benjamin, Director
Received 2,880 shares as a grant or award |
| 16 Sep 2026 |
Form 3: Letham Thomas Benjamin, Director
No securities owned |
| 15 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
McLean, VA — September 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that its Board of Directors (“Board”) has appointed Ben Letham as a director, ef... |
| 31 Aug 2026 |
Form 4: Dalton Travis, Director
Bought 4,500 shares ($175K) · Bought 1,950 shares ($75K) |
| 18 Aug 2026 |
Form 4: Misencik Tiffani, SVP, Chief Growth Officer
Sold 8,850 shares ($355K) |
| 14 Aug 2026 | 144 |
| 12 Aug 2026 |
Form 4: Mintz William B., SVP, Chief Strategy Officer
Sold 8,431 shares ($289K) |
| 10 Aug 2026 | 144 |
| 07 Aug 2026 |
Form 4: Mintz William B., SVP, Chief Strategy Officer
Gave up 3,622 shares to cover exercise price or tax ($94.6K) |
| 07 Aug 2026 |
Form 4: Garis Douglas Michael, EVP&CFO
Gave up 11,711 shares to cover exercise price or tax ($306K) |
| 07 Aug 2026 | 10-Q |
| 07 Aug 2026 | 8-K: Results of Operations and Financial Condition |
Loading...